Fundamental Data for SGP

SCHERING P(NYSE:SGP)

Schering-Plough Corporation and its subsidiaries are engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. The company operates primarily in the prescription pharmaceutical marketplace. However, where appropriate, the company has sought regulatory approval to switch prescription products to over-the-counter status as a means of extending a product''s life cycle.

# Employees: 51000

Address: 2000 Galloping Hill Road,Kenilworth,,USA

Phone: 908 298-4000

Fax: 908 298-7082

Website: www.schering-plough.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Fred Hassan (Chrmn.; C.E.O.)

Ron C. Cheeley (Sr. V.P.; Global Human Resou.)

Robert J. Bertolini (Exec. V.P.; C.F.O.)

Patricia F. Russo (Dir.)

Raul E. Kohan (Sr. V.P.; Corp. Excellence,)

Dividend

Ex-Dividend Date: 10/22/2009

Annual Dividend: $0.26

Current Dividend Yield: $0.92

Dividend Paid (3 months): $0.12

Indicated Dividend: $0.14

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/9/2010

Mean EPS (Next Qtr): $0.40

Mean EPS (Year): $1.82

Mean Estimate(Long Term): $7.00

P/E Ratio(Based on EPS estimate): 15.470

Number of Estimates: 16

Shares Performance

Period	SGP	Compare to S&P
YTD	65.59 %	44.35 %
4 Weeks	0.07 %	-0.99 %
12 Weeks	5.94 %	3.31 %

Shares Information

Analyst Coverage: Y

Avg Volume: 20783630

Shares Outstanding: 1633M

Market Cap: $46.08B

52 Week High: $29.71

52 Week Low: $13.44

P/E Ratio: 15.580

PEG Ratio: 2.210

Split: On 12/3/1998 SGP split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -13.04 %

EPS Growth in Last Year: 2.56 %

Sales Growth in Last Quarter: -3.18 %

Sales Growth in Last Quarter: -1.68 %

Financials

Qtr Book Value: $4.83

Cash Flow/Share: $8.84

Change in Payout Ratio: -0.010

Price/Sales: 2.580